Submitted by Anonymous (not verified) on 10 October 2023 - 12:35
Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Lupus Erythematosus, Systemic, Date of authorisation: 14/02/2022, Revision: 3, Status: Authorised
Source: